Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II

Charles V. Pollack, Anatoly Langer(University of Toronto), Shaun G. Goodman(University of Toronto), Matthew T. Roe(Clinical Research Institute), Jyotsna Mulgund(University of North Carolina at Chapel Hill), Anita Y. Chen(University of Rochester Medicine), Eric D. Peterson(The University of Texas Southwestern Medical Center), Mohammad I. Zia(Canadian Heart Research Centre), Mary Tan(Canadian Heart Research Centre), W. Brian Gibler(University of Cincinnati), E. Magnus Ohman(Clinical Research Institute)
UNC Libraries
November 9, 2020
10.17615/y2qp-q465
Cited by 0

Related Papers

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
|Circulation|2009|1k
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
|Circulation|2008|757
Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
|Journal of the American College of Cardiology|2005|658